Similar findings reported that miR-146a, through the inhibition of IRAK1, retards tumor progression in lung adenocarcinoma cells, and the invasive potential of cervical and colorectal cancer (CRC) cells [63,64]. Here, IRAK1 is linked to neoplasm.